What About Dads? How We Can Improve Screening for Perinatal Mood and Anxiety Disorders
Although up to 10% of new fathers may experience mental health challenges, we do not regularly screen this population.
Although up to 10% of new fathers may experience mental health challenges, we do not regularly screen this population.
Every week we review the most recent publications in women’s mental health.
A New Drug Application was submitted to the FDA for a novel, nonhormonal dual neurokinin-1 and neurokinin-3 receptor antagonist for the treatment of menopause-related vasomotor symptoms.
Those with depression are at greater risk of experiencing IPV and experiencing IPV is associated with higher levels of depressive symptoms.
Best wishes for the holiday season from the Center for Women's Mental Health.
Happy Thanksgiving from the MGH Center for Women's Mental Health
To address the growing demand for specialized knowledge in perinatal psychiatry, the Center for Women's Mental Health is pleased to announce its newest CME course offering: Perinatal Psychiatry: In Depth Modules for Enhanced Approaches. [...]
Back by popular demand, the CWMH is pleased to announce a second course offering of 'Psychiatric Disorders in Women' with the MGH Psychiatry Academy. The course will run this Summer, and is available to all [...]
Mom Congress is a three-day event that brings together moms and those who support them to talk with government leaders about what matters most in maternal and child health — from the care we [...]
We completed our first MGH Women’s Mental Health online CME program in the Fall of 2019, and we are excited to offer the next round of the course in the series. Thank you for those [...]